Fig. 1.

Overview of the study design. Expression of hsv1-miRH18 and hsv2-miR-H9-5p was assessed in 192 prostate cancer (CaP) tissues and 131 benign prostatic hyperplasia (BPH) noncancerous tissues. Then, expression of these microRNAs (miRNAs) was compared between matched cancerous and surrounding noncancerous tissues from 41 patients, as well as in noncancerous tissues from BPH patients. Lastly, the 2 miRNAs were directly stained in cancerous tissues, surrounding noncancerous tissues, and BPH tissues.